Healthtech Solutions Inc.

Healthtech Solutions Inc.

HLTT
Healthtech Solutions Inc.US flagOther OTC
0.00
USD
-NaN
- -
10,663.00Market Cap
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2019 Y
2020 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
0.3
0.41
0.5
0.68
0.44
0.42
- -
- -
- -
- -
0.02
0.03
Basic EPS, GAAP
0.04
0.07
0.11
0.15
0.05
0.05
- -
- -
-0.61
-0.31
-0.04
-0.05
Free Cash Flow per Basic Share
-0.01
0.1
-0.01
-0.09
0.21
0.04
- -
- -
-0.53
-0.04
-0.04
-0.04
Dividend per Share
- -
0.07
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.07
0.07
0.15
0.31
0.36
0.41
- -
- -
-1.19
-0.36
-0.2
-0.2
Tangible Book Value per Share
0.25
0.37
0.39
0.61
0.7
0.78
- -
- -
-0.49
-0.02
-0.05
-0.05
Basic Weighted Avg Shares
18
19
24
20
19
19
10
10
1
29
68
67
Sales/Revenue/Turnover
5
8
12
14
9
8
- -
- -
- -
- -
2
2
Operating Margin (%)
16.72
20.05
24.9
24.54
16.09
16.44
- -
- -
- -
- -
-204.85
-204.85
Depreciation Expense
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
1
1
3
3
1
1
- -
- -
-1
-9
-3
-3
Effective Tax Rate (%)
13.74
0.25
- -
9.48
13.3
12.94
- -
- -
- -
- -
- -
- -
Profit Margin (%)
13.04
17.84
21.75
22.2
12.18
11.44
- -
- -
- -
- -
-180.34
-180.27
Working Capital
3
4
2
7
8
10
- -
- -
- -
-1
-3
-3
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
5
7
10
13
15
16
- -
- -
-1
-1
-3
-3
Return on Invested Capital (%)
- -
27
36.61
26.28
7.71
6.07
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
69.3
72.01
45.07
10.43
7.8
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
108.97
109.99
62.42
15.8
12.44
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jun'22
Sep'22
Dec'22
ST Debt
2
3
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
67
70
72
Market Capitalization
13
23
19

Working Capital

FRC

in mil. unless spec.
Jun'22
Sep'22
Dec'22
Total Current Assets
- -
1
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
1
1
Inventories
- -
- -
- -
Total Current Liabilities
3
4
6
Payables & Accruals
1
2
2
ST Debt
2
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
214.06%
397.64%
374.84%
Free Cash Flow
- -
- -
109.36%
Net Income, GAAP
355.5%
685.73%
-66.59%
Sales/Revenue/Turnover
- -
- -
-79.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
1
1
2

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
-0.61
2021
-0.03
-0.23
-0.04
- -
-0.31
2022
-0.01
-0.01
-0.01
- -
-0.04

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
James Pesoli
Full Time Employees
18
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
181 Dante Avenue Tuckahoe NY United States of America 10707
IPO Date
Oct 4, 2006
Business
Healthtech Solutions Inc. (HLTT) operates as a life sciences company focused on developing and commercializing innovative healthcare solutions through its subsidiaries, including Healthtech Wound Care Inc., Cellsure LLC, The Clia Lab Inc., Medi-Scan Inc., RevHeart Inc., and World Reach Holdings LLC. The company offers a portfolio of wound care products such as DermaBind, a patented dehydrated placental membrane allograft for treating burns, post-surgery incisions, diabetic foot ulcers, and chronic wounds; EnduraKit, an opioid-free long-lasting local anesthetic; advanced ultrasound imaging software enhanced by artificial intelligence for chest and musculoskeletal applications; heart rhythm analysis technology to generate curative waveforms for damaged cardiac signals; and diagnostic laboratory services via its CLIA-certified and ISO 13485 facilities in Salt Lake City, Utah. Founded in 2018 and headquartered at 181 Dante Avenue, Tuckahoe, New York, Healthtech Solutions primarily serves healthcare providers, hospitals, long-term care facilities, nursing homes, podiatry offices, government agencies, and international partners across North America. In March 2023, the company completed the acquisition of a 51% majority interest in World Reach Holdings LLC for an undisclosed amount of cash and stock, strengthening its nationwide and global distribution network, expanding laboratory capabilities to 16,000 square feet, and enabling joint commercialization of new wound care kits and other products; additionally, in June 2025, James Pesoli, president and director, was appointed chief executive officer.

Company News

APIChatGPT
  • TMA Solutions Launched New HealthTech Solutions Driving Innovation in Healthcare

  • Healthtech Solutions, Inc. Announces Appointment of Paul Mann to the Board of Directors